How should norepinephrine 4 mg be prepared in 250 mL 5% dextrose in water (D5W), what is its indication, and what formula is used to calculate the infusion dose and rate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Norepinephrine Preparation in D5W

Yes, you can prepare norepinephrine 4mg in 250mL D5W, which creates a concentration of 16 mcg/mL—this is a standard and FDA-approved preparation method. 1

Standard Preparation Method

The FDA label explicitly describes this preparation 1:

  • Add 4mg (one 4mL vial) of norepinephrine to 250mL of D5W
  • Final concentration: 16 mcg/mL
  • D5W is the preferred diluent as it protects against oxidation and loss of potency
  • This solution is chemically stable for 7 days at room temperature under ambient light 2

Alternative Standard Concentration

The FDA also describes a more dilute preparation 1:

  • Add 4mg to 1000mL D5W = 4 mcg/mL concentration
  • This is useful when patients require larger fluid volumes

Clinical Indication

Norepinephrine is the first-choice vasopressor for septic shock and other forms of distributive shock 3. The Surviving Sepsis Campaign 2016 guidelines give this a strong recommendation with moderate quality evidence. It should be used to target a mean arterial pressure (MAP) of 65 mmHg 3.

Dosing Formula and Rate Calculation

Starting Dose

  • Initial rate: 8-12 mcg/min (equivalent to 0.5-0.75 mL/min of the 16 mcg/mL solution) 1
  • Titrate to achieve MAP ≥65 mmHg

Maintenance Dose

  • Average: 2-4 mcg/min (0.125-0.25 mL/min of 16 mcg/mL solution) 1
  • Dosing must be individualized based on hemodynamic response

Dose Calculation Formula

For 16 mcg/mL concentration (4mg in 250mL):

Rate (mL/hr) = Desired dose (mcg/min) × 60 ÷ 16

OR

Rate (mL/hr) = Desired dose (mcg/min) × 3.75

Example calculations:

  • For 8 mcg/min: 8 × 3.75 = 30 mL/hr
  • For 12 mcg/min: 12 × 3.75 = 45 mL/hr
  • For 4 mcg/min: 4 × 3.75 = 15 mL/hr

Weight-Based Dosing Formula

When dosing by weight (mcg/kg/min):

Rate (mL/hr) = Dose (mcg/kg/min) × Weight (kg) × 60 ÷ Concentration (mcg/mL)

For 16 mcg/mL:
Rate (mL/hr) = Dose (mcg/kg/min) × Weight (kg) × 3.75

Example for 70kg patient:

  • Low dose (0.05 mcg/kg/min): 0.05 × 70 × 3.75 = 13 mL/hr
  • Moderate dose (0.2 mcg/kg/min): 0.2 × 70 × 3.75 = 52.5 mL/hr
  • High dose (0.5 mcg/kg/min): 0.5 × 70 × 3.75 = 131 mL/hr

Dose Severity Classification

Recent evidence suggests specific cutoffs for norepinephrine dose severity 4:

  • Low dose: <0.2 mcg/kg/min (mortality ~14%)
  • Intermediate dose: 0.2-0.4 mcg/kg/min (mortality ~26%)
  • High dose: >0.4 mcg/kg/min (mortality ~40%)

Doses >1.13 mcg/kg/min predict high early mortality (sensitivity 67%, specificity 80%) 5.

Critical Administration Guidelines

Route of Administration

  • Preferred: Central venous catheter through a large vein 1
  • Peripheral administration is acceptable when central access is delayed, using:
    • ≥18 gauge IV at or above antecubital fossa
    • Maximum peripheral dose: 20 mcg/min
    • Low extravasation rate (2.3-4.5%) when protocol followed 6, 7

Important Caveats

Volume depletion must be corrected first 1. The FDA label explicitly states norepinephrine should not be used as a substitute for blood volume replacement. Occult hypovolemia should be suspected if extremely high doses are required.

Phentolamine is the antidote for extravasation: Inject 5-10mg diluted in 10-15mL saline into the extravasation site 1.

Salt vs. Base confusion: The vial contains norepinephrine bitartrate salt, but dosing is expressed as norepinephrine base. The 4mg/4mL vial contains 4mg of norepinephrine base—this is already accounted for in the labeling 1, 8.

Protect from light for extended storage: While stable for 7 days at room temperature, solutions protected from light maintain >90% concentration for 61 days at 4°C 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.